NAVIGATE Kidney program to reduce gaps in care for people with advanced CKD
Official title: Navigate Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities Among Individuals With Kidney Disease
Run by University of Colorado, Denver · NCT06810622 · Data updated 2026-11-12
This project will test whether a community health worker–led NAVIGATE-Kidney program helps adults with advanced CKD (eGFR 15–29) start kidney replacement treatment more safely and avoid early catheter use or premature death.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 448 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 2 sites (Denver, Colorado and 1 other locations) |
| Status | Recruiting |
| Started | March 18, 2026 |
| Main results expected | May 15, 2029 |
| Study ends | May 15, 2029 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT06810622 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with advanced kidney disease (eGFR 15–29 mL/min/1.73 m2) who are not pregnant, not incarcerated, without prior kidney transplant or prior dialysis access surgery, and who are willing and able to participate at the study sites are ideal candidates.
✕Probably not a fit
People already on chronic dialysis, those with prior kidney transplant or prior dialysis access surgery, those choosing conservative or palliative care, and individuals who are pregnant, incarcerated, have moderate to severe dementia, are deaf, or lack health insurance are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The NAVIGATE-Kidney project compares a multilevel intervention led by community health workers to standard care for adults with advanced CKD stage 4/5 (eGFR 15–29 mL/min/1.73 m2). The primary composite outcome is time to transition to kidney replacement therapy with central venous catheter use or death, with secondary clinical outcomes including rates of optimal KRT starts and process measures. Patient-centered measures include patient activation, decisional conflict, and social challenges, and the team will also assess implementation using the PRISM framework and perform an economic evaluation. The trial is being conducted at sites affiliated with the University of Colorado and the University of New Mexico and builds on prior NAVIGATE work in maintenance hemodialysis populations.
Why it matters
Potential benefit: If successful, NAVIGATE-Kidney could reduce early catheter use and improve the safety and planning of dialysis starts while improving patient activation and decision-making.
How similar studies have gone: Community health worker approaches and the team’s prior NAVIGATE work in maintenance hemodialysis have shown promise, but applying this multilevel model to people with stage 4 CKD is a novel extension.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults ≥ 18 years of age, * Adults who are not pregnant, * Adults who are not incarcerated, * Adults who have advanced kidney disease with an eGFR of 15-29 mL/min/1.73m2). No other measures are used to identify eligible patients. Exclusion Criteria: * Previous kidney transplant * Previous surgery for dialysis such as an arteriovenous fistula, arteriovenous graft, or peritoneal dialysis catheter placement * On chronic dialysis * Conservative management or primary goal is palliation * Incarcerated * Pregnant\* * Under 18 years of age * Moderate to severe dementia * Deaf persons * Lacking health insurance\*\* * Investigator Discretion: Individuals who, in the judgment of the Site PI (or designee), are deemed unsuitable for participation due to behavioral or logistical circumstances that could compromise study integrity or the safety of the participant or staff.
Where it's running
-
Denver Health and Hospital Authority
Denver, Colorado, United States Recruiting -
University of New Mexico Health Science Center
Albuquerque, New Mexico, United States Not yet recruiting
Study contacts
- Principal investigator: Lilia Cervantes, MD — University of Colorado-Anschutz SOM-Hospital Medicine
- Study coordinator: Lilia Cervantes, MD
- Email: lilia.cervantes@cuanschutz.edu
- Phone: 3036418009
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Impact of TAVR on kidney function in people with aortic valve disease
This registry tests how trans-catheter aortic valve implantation affects kidney function and the risk of kidney injury in adults with aortic stenosis.
-
Calciphylaxis in people with chronic kidney disease: causes, risks, and early signs
This project will compare adults with chronic kidney disease who develop calciphylaxis to matched CKD patients who do not, collecting clinical data and biological samples to try to find risk factors and early signs.
-
Improving measures of nutrition, inflammation, kidney function, body composition, and hydration in older adults
This project will test whether modern blood tests and body-measure techniques give more accurate estimates of nutrition and kidney health for hospitalized people aged 65 and older.
-
Transformative 2.0 for diabetic kidney disease
This project will try to see if adults with diabetic kidney disease who take SGLT2 diabetes medicines have different biological patterns in archived kidney tissue than similar people who do not take these medicines.
-
21-day comprehensive spa care for kidney and urinary conditions
This program will try a 21-day spa treatment with mineral water baths, drinking cures, exercise and diet for adults 40–70 who have chronic kidney or urinary problems to see if it improves symptoms and kidney health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.